[1]
Antonini, M. et al. 2021. EVALUATION OF BONE MINERAL DENSITY LOSS IN PATIENTS WITH BREAST CANCER USING AROMATASE INHIBITORS AS ADJUVANT ENDOCRINE THERAPY: 5-YEAR FOLLOW-UP. Mastology. 31, (Oct. 2021), 32.